ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 141,46
-0,67%
Dow Jones
39 838,26
0,08%
DAX
18 726,76
-0,21%
Brent Oil
82,815
-0,86%
Bitcoin
69 504,43
-2,72%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Baxter International Inc (BAX)

  7. Baxter International Inc (BAX) Actualités

BAX

Baxter (BAX)

Baxter International Inc
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:BAX
DateHeureSourceTitreSymboleSociété
15/05/202420h42Edgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesNYSE:BAXBaxter International Inc
15/05/202420h00Business WireBaxter Announces Mission and Logo for Proposed Kidney Care Company VantiveNYSE:BAXBaxter International Inc
13/05/202414h45Business WireBaxter Secures FDA Approval of Clinolipid (Lipid Injectable Emulsion) Neonatal and Pediatric IndicationNYSE:BAXBaxter International Inc
09/05/202422h36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BAXBaxter International Inc
09/05/202422h27Edgar (US Regulatory)Form 8-K - Current reportNYSE:BAXBaxter International Inc
07/05/202422h31Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:BAXBaxter International Inc
07/05/202422h15Business WireBaxter to Present at Bank of America 2024 Health Care ConferenceNYSE:BAXBaxter International Inc
07/05/202414h30Business WireBaxter Declares Quarterly DividendNYSE:BAXBaxter International Inc
02/05/202413h15Business WireBaxter Reports First-Quarter 2024 ResultsNYSE:BAXBaxter International Inc
11/04/202414h30Business WireBaxter Expands Pharmaceuticals Portfolio with New Injectable Products in the U.S.NYSE:BAXBaxter International Inc
10/04/202422h15Business WireBaxter to Host First-Quarter 2024 Financial Results Conference Call for InvestorsNYSE:BAXBaxter International Inc
01/04/202413h15Business WireBaxter Announces U.S. FDA Clearance of Novum IQ Large Volume Infusion Pump and Dose IQ Safety Software, Advancing Connected and Intelligent Infusion TherapyNYSE:BAXBaxter International Inc
27/03/202414h00Business WireBaxter to Host Annual Meeting of Stockholders in Virtual FormatNYSE:BAXBaxter International Inc
01/03/202422h23Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:BAXBaxter International Inc
29/02/202422h15Business WireBaxter to Present at Raymond James 45th Annual Institutional Investors ConferenceNYSE:BAXBaxter International Inc
21/02/202422h00GlobeNewswire Inc.Spectral Medical Announces Amendment and Extension of Exclusive Supply and Distribution Agreement With Baxter Healthcare CorporationNYSE:BAXBaxter International Inc
15/02/202413h41GlobeNewswire Inc.Spectral Medical Announces Major Milestone by Reaching Its Interim Enrollment Target of 90 PatientsNYSE:BAXBaxter International Inc
14/02/202422h58Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NYSE:BAXBaxter International Inc
13/02/202419h08Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNYSE:BAXBaxter International Inc
08/02/202423h29Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NYSE:BAXBaxter International Inc
08/02/202413h15Business WireBaxter Reports Fourth-Quarter and Full-Year 2023 ResultsNYSE:BAXBaxter International Inc
23/01/202422h14Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:BAXBaxter International Inc
18/01/202414h00Business WireBaxter Funds University Scholarships to Support Students From Underrepresented Groups and Communities in the UK and IrelandNYSE:BAXBaxter International Inc
04/01/202422h15Business WireBaxter to Host Fourth-Quarter 2023 Financial Results Conference Call for InvestorsNYSE:BAXBaxter International Inc
14/12/202314h00Business WireBaxter Advances First Intravenous (IV) Bag Recycling Pilot for U.S. HospitalsNYSE:BAXBaxter International Inc
13/12/202322h30Business WireBaxter to Present at 42nd Annual J.P. Morgan Healthcare ConferenceNYSE:BAXBaxter International Inc
11/12/202315h00Business WireBaxter Publishes Task Force on Climate-Related Financial Disclosures (TCFD) Report and Is Named to Dow Jones Sustainability Index North AmericaNYSE:BAXBaxter International Inc
04/12/202314h00GlobeNewswire Inc.Spectral Medical Provides November Tigris Trial UpdateNYSE:BAXBaxter International Inc
28/11/202315h00Business WireThe Baxter International Foundation and UNICEF Partner to Expand Access to Safe Water and Sanitation in EgyptNYSE:BAXBaxter International Inc
06/11/202314h30Business WireBaxter Highlights New Data at Kidney Week Indicating Sharesource Is Associated With a 77% Lower Risk of Home Dialysis Technique FailureNYSE:BAXBaxter International Inc
 Showing the most relevant articles for your search:NYSE:BAX

Dernières Valeurs Consultées

NYSE
NKE
Nike
COIN
ETHUSD
Ethereum
EU
BN
Danone
NASDAQ
AMZN
Amazon.com
EU
BNP
BNP Paribas
EU
DG
Vinci
EU
PX1
CAC 40
NASDAQ
MSFT
Microsoft
EU
MC
Lvmh Moet Hennessy Louis...
EU
ML
Michelin
NYSE
JPM
JP Morgan Chase
NASDAQ
AAPL
Apple
EU
BEL20
Bel 20
EU
PX4
SBF 120
EU
GLE
Societe Generale
NYSE
KO
Coca Cola
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés